| |
| |
|
| Insider
Information: |
Leen Ann M. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,006 |
|
|
Indirect Shares
|
2,288,154 |
|
|
| Direct
Value |
$98,684 |
|
|
|
Indirect Value
|
$1,820,913 |
|
|
| Total
Shares |
2,412,160 |
|
|
| Total
Value |
$1,919,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allovir Inc |
ALVR |
Chief Scientific Officer |
2023-02-02 |
124,006 |
2023-02-02 |
2,288,154 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
124,006 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2022-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
43,000 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
65,256 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
23,256 |
51,256 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-05-10 |
4 |
S |
$22.75 |
$3,412,500 |
I/I |
(150,000) |
2,309,142 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-03-16 |
4 |
AS |
$30.00 |
$90,751 |
I/I |
(3,025) |
2,459,142 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
AS |
$38.46 |
$368,329 |
I/I |
(9,518) |
2,462,167 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-23 |
4 |
AS |
$38.83 |
$165,876 |
I/I |
(4,199) |
2,471,685 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-22 |
4 |
AS |
$41.54 |
$242,880 |
I/I |
(5,706) |
2,475,884 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-19 |
4 |
AS |
$41.75 |
$314,868 |
I/I |
(7,541) |
2,481,590 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-18 |
4 |
AS |
$39.20 |
$110,194 |
I/I |
(2,700) |
2,489,131 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-17 |
4 |
AS |
$38.63 |
$92,468 |
I/I |
(2,286) |
2,491,831 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
AS |
$41.82 |
$127,733 |
I/I |
(3,050) |
2,494,117 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
28,000 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2020-11-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,394 |
60,394 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2020-11-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,394 |
0 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific Officer |
• – – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
2,436,773 |
2,436,773 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Scientific OfficerOffice |
• – – |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,394 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
